High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma

Journal of the American Academy of Dermatology

Volumn 62, Issue 6, 2010, Pages 995-1004

  Schlapbach, Christoph ^a   Ochsenbein, André ^a   Kaelin, Ursula ^a   Hassan, Akmal S ^a   Hunger, Robert E ^a   Yawalkar, Nikhil ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

CTCL; cutaneous T cell lymphoma; DC SIGN CD209; dendritic cell; dendritic cell subsets; mycosis fungoides; S zary syndrome; tumor immunology

Indexed keywords

CD209 ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DENDRITIC CELL; DIGITAL IMAGING; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MALE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SEZARY SYNDROME; SKIN DEFECT; T LYMPHOCYTE SUBPOPULATION; TISSUE DISTRIBUTION;

ADULT; AGED; ANTIGENS, CD; CELL ADHESION MOLECULES; DENDRITIC CELLS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; LECTINS, C-TYPE; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; RECEPTORS, CELL SURFACE; SEZARY SYNDROME; SKIN; SKIN NEOPLASMS; T-LYMPHOCYTES, REGULATORY;

EID: 77951903751     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.06.082     Document Type: Article

References (22)

1. Burg G., Kempf W., Cozzio A., Feit J., Willemze R., S Jaffe E., et al. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol 32 (2005) 647-674
2. Edelson R.L. Cutaneous T cell lymphoma: the helping hand of dendritic cells. Ann N Y Acad Sci 941 (2001) 1-11
3. Bagot M., Nikolova M., Schirm-Chabanette F., Wechsler J., Boumsell L., and Bensussan A. Crosstalk between tumor T lymphocytes and reactive T lymphocytes in cutaneous T cell lymphomas. Ann N Y Acad Sci 941 (2001) 31-38
4. Ferenczi K., Fuhlbrigge R.C., Pinkus J., Pinkus G.S., and Kupper T.S. Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 119 (2002) 1405-1410
5. Rook A.H., Gottlieb S.L., Wolfe J.T., Vowels B.R., Sood S.S., Niu Z., et al. Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis. Clin Exp Immunol 107 Suppl. 1 (1997) 16-20
6. Chaput N., Conforti R., Viaud S., Spatz A., and Zitvogel L. The Janus face of dendritic cells in cancer. Oncogene 27 (2008) 5920-5931
7. Steinman R.M., and Banchereau J. Taking dendritic cells into medicine. Nature 449 (2007) 419-426
8. Ueno H., Klechevsky E., Morita R., Aspord C., Cao T., Matsui T., et al. Dendritic cell subsets in health and disease. Immunol Rev 219 (2007) 118-142
9. Kaiko G.E., Horvat J.C., Beagley K.W., and Hansbro P.M. Immunological decision-making: how does the immune system decide to mount a helper T-cell response?. Immunology 123 (2008) 326-338
10. Wysocka M., Zaki M.H., French L.E., Chehimi J., Shapiro M., Everetts S.E., et al. Sezary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines. Blood 100 (2002) 3287-3294
11. Olsen E., Vonderheid E., Pimpinelli N., Willemze R., Kim Y., Knobler R., et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110 (2007) 1713-1722
12. Schlapbach C., Yawalkar N., and Hunger R.E. Human beta-defensin-2 and psoriasin are overexpressed in lesions of acne inversa. J Am Acad Dermatol 61 (2009) 58-65 Epub 2009 Feb 26
13. de Saint-Vis B., Vincent J., Vandenabeele S., Vandervliet B., Pin J.J., Ait-Yahia S., et al. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 9 (1998) 325-336
14. McGinness J.L., Bivens M.M., Greer K.E., Patterson J.W., and Saulsbury F.T. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature. J Am Acad Dermatol 55 (2006) 143-148
15. Dunn G.P., Old L.J., and Schreiber R.D. The three Es of cancer immunoediting. Annu Rev Immunol 22 (2004) 329-360
16. Gijzen K., Raymakers R.A., Broers K.M., Figdor C.G., and Torensma R. Interaction of acute lymphopblastic leukemia cells with C-type lectins DC-SIGN and L-SIGN. Exp Hematol 36 (2008) 860-870
17. Ladanyi A., Kiss J., Somlai B., Gilde K., Fejos Z., Mohos A., et al. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor. Cancer Immunol Immunother 56 (2007) 1459-1469
18. Berger C.L., Hanlon D., Kanada D., Dhodapkar M., Lombillo V., Wang N., et al. The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells. Blood 99 (2002) 2929-2939
19. Berger C.L., Tigelaar R., Cohen J., Mariwalla K., Trinh J., Wang N., et al. Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells. Blood 105 (2005) 1640-1647
20. Cen P., Duvic M., Cohen P.R., and Kurzrock R. Increased cancer antigen 27.29 (CA27.29) level in patients with mycosis fungoides. J Am Acad Dermatol 58 (2008) 382-386
21. Weiss J.M., Subleski J.J., Wigginton J.M., and Wiltrout R.H. Immunotherapy of cancer by IL-12-based cytokine combinations. Expert Opin Biol Ther 7 (2007) 1705-1721
22. Nguyen V., Huggins R.H., Lertsburapa T., Bauer K., Rademaker A., Gerami P., et al. Cutaneous T-cell lymphoma and Staphylococcus aureus colonization. J Am Acad Dermatol 59 (2008) 949-952